Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.720
+0.120 (7.50%)
At close: Jan 22, 2026, 4:00 PM EST
1.720
0.00 (0.00%)
After-hours: Jan 22, 2026, 6:18 PM EST

Allogene Therapeutics Revenue

In the year 2024, Allogene Therapeutics had annual revenue of $22.00K, down -76.84%.

Revenue (ttm)
$22.00K
Revenue Growth
-76.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
229
Market Cap
386.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.00K-73.00K-76.84%
Dec 31, 202395.00K-61.00K-39.10%
Dec 31, 2022156.00K-113.93M-99.86%
Dec 31, 2021114.09M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology212.00M
Enanta Pharmaceuticals65.32M
XOMA Royalty47.11M
Foghorn Therapeutics24.52M
AC Immune5.48M
Revenue Rankings

ALLO News

More News